Evidence map›Paper›PMID 34333755›Full record

ArticleImmunologic research2021

A novel ITGB2 variant with long survival in patients with leukocyte adhesion defect type-I.

Mehmet Halil Celiksoy, Mustafa Yavuz Köker, Alper Gezdirici, Sevil Ozsoy, Baris Malbora, Songul Gungor

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Immunologic research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Mehmet Halil CeliksoyDepartment of Pediatric Allergy and Immunology, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey. drmhc@hotmail.com.ORCID 0000-0002-4164-4668
Mustafa Yavuz KökerDepartment of Immunology, Medical Faculty, Erciyes University, Kayseri, Turkey.
Alper GezdiriciDepartment of Medical Genetics, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.
Sevil OzsoyDepartment of Immunology, Medical Faculty, Erciyes University, Kayseri, Turkey.
Baris MalboraDepartment of Pediatric Hematology, Bone Marrow Transplantation Center, Gaziosmanpasa Hospital, Yeniyuzyıl University, Istanbul, Turkey.
Songul GungorDepartment of Immunology, Medical Faculty, Erciyes University, Kayseri, Turkey.
Erciyes University · TRIstanbul Metropolitan Municipality · TRIstanbul Yeni Yüzyıl University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leukocyte adhesion deficiency is an autosomal recessive primary immunodeficiency that has been divided into three types: LAD1 (beta-2 integrin (CD18) family deficiency/defect), LAD2 (absence of fucosylated carbonhydrate ligands for selectins) and LAD3 (defective activation of all beta integrins). However, recently LAD4 has been described in cystic fibrosis patients, with a defect in integrin activation reported in monocytes. LAD-I is the most common type and prevalence of 1 in 1,000,000 live births. Clinical features of LAD patients are recurrent bacterial and fungal infections, omphalitis with delayed umbilical stump separation, significant leukocytosis especially neutrophilia during infection periods, impaired pus formation, and delayed traumatic or surgical wound healing. Flow cytometry is considered a useful tool for rapid diagnosis of the disease. The study of CD18 and CD11 (a, b, c) expression patterns in peripheral blood leukocytes helps to distinguish different phenotypes of LAD-I. In general, patients with ≥ 2% CD18 expression tend to have a less severe infection and often survive until adulthood, whereas < 2% CD18 expression often results in death in infancy. In this case report, three siblings, 10, 15, and 17 years old, diagnosed with leukocyte adhesion defect type 1 in adolescence age group, are presented.

Indexed as

MutationAdolescentBiomarkersCD18 AntigensDNA Mutational AnalysisFemaleHumansImmunophenotypingLeukocyte-Adhesion Deficiency SyndromeMaleMoralsPedigreePhenotypePrognosisSkinSymptom AssessmentBiomarkersCD18 AntigensAdolescenceChildrenImmunodeficiencyLeukocyte adhesion defect

Identifiers

PMID34333755
OpenAlexW3192960987

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.